Patient preferences for coronary artery bypass graft surgery or percutaneous intervention in multivessel coronary

Ryan Kipp1, James Lehman, Jacqueline Israel

  • 1Division of Cardiovascular Medicine, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

Insights

Patients with multivessel coronary artery disease (mv-CAD) prefer percutaneous coronary intervention (mv-PCI) over coronary artery bypass graft surgery (CABG), even with higher risks. Physicians showed greater risk aversion than patients when choosing between mv-PCI and CABG.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiovascular Surgery

Background:

  • Patient risk perception and treatment preferences for multivessel coronary artery disease (mv-CAD) remain unclear.
  • Understanding these preferences is crucial for shared decision-making in revascularization strategies.

Purpose of the Study:

  • To determine patient preference between multivessel percutaneous coronary intervention (mv-PCI) and coronary artery bypass graft surgery (CABG) for symptomatic mv-CAD.
  • To compare patient and physician preferences for these revascularization methods under varying risk scenarios.

Main Methods:

  • A hypothetical scenario of medically refractory mv-CAD was presented to 585 patients and 31 physicians.
  • Participants indicated their preferred treatment (mv-PCI or CABG) based on variable 1-year risks of death, stroke, and repeat procedures for mv-PCI versus fixed risks for CABG.
  • Statistical analysis calculated the odds of favoring mv-PCI over CABG across different risk levels.

Main Results:

  • Patients overwhelmingly preferred mv-PCI over CABG, even when mv-PCI carried double the risk of death or triple the risk of repeat procedures.
  • Physicians were more risk-averse than patients, opting for CABG more frequently as the quoted risks for mv-PCI increased.
  • Physician preference for mv-PCI decreased significantly with higher risks compared to patient preference.

Conclusions:

  • Patients demonstrate a strong preference for mv-PCI over CABG for treating mv-CAD, irrespective of significantly higher associated risks.
  • Physicians' treatment preferences are more closely aligned with objective risk assessment than patient preferences.
  • This highlights a potential discordance between patient desires and physician-recommended strategies in mv-CAD management.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...